M&A Deal Summary

Ergomed Acquires ADAMAS

On February 9, 2022, Ergomed acquired business services company ADAMAS for 26M GBP

Acquisition Highlights
  • This is Ergomed’s 2nd transaction in the Business Services sector.
  • This is Ergomed’s largest (disclosed) transaction.
  • This is Ergomed’s 2nd transaction in the United Kingdom.

M&A Deal Summary
Date 2022-02-09
Target ADAMAS
Sector Business Services
Buyer(s) Ergomed
Deal Type Add-on Acquisition
Deal Value 26M GBP

Target

ADAMAS

Berkshire, United Kingdom
ADAMAS is an international specialist consultancy offering a full range of independent quality assurance services and specialising in the auditing of pharmaceutical manufacturing processes, as well as auditing clinical trials and pharmacovigilance systems. ADAMAS was founded in 1997 and is based in Berkshire, United Kingdom.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ergomed

Guildford, United Kingdom
Category Company
Founded 1997
Sector Life Science
Employees1,371
Revenue 119M GBP (2021)
DESCRIPTION

Ergomed is a profitable UK-based business providing drug development services to the pharmaceutical industry and has a growing portfolio of co-development partnerships. It operates in over 50 countries. Ergomed provides clinical development, trial management and pharmacovigilance services to over 100 clients ranging from top 10 pharmaceutical companies to small and mid-sized drug development companies. Ergomed was founded in 1997 and is based in Guildford, the United Kingdom.

DEAL STATS #
Overall 8 of 8
Sector (Business Services) 2 of 2
Type (Add-on Acquisition) 7 of 7
Country (United Kingdom) 2 of 2
Year (2022) 1 of 1
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-14 MedSource

Houston, Texas, United States

MedSource is a specialized clinical research organization with a focus on complex diseases and study designs. MedSource delivers high-quality clinical trials specializing in oncology and rare disease. With over 20 years’ experience, MedSource has participated in more than 200 oncology and rare disease clinical trials. MedSource was founded in 1997 and is based in Houston, Texas.

Buy $16M
Mergr

Product

Company

Legal